Drug Markets/Plecanatide

Plecanatide

1 NDC across 1 manufacturer|0 Generic,1 Brand

Plecanatide is used to treat constipation, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jan 19, 2017. In 2024, Medicare Part D spent $123 million on Plecanatide across 155,000 claims for 45,000 beneficiaries.

Plecanatide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $18.05 to $18.05 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$18.05 – $18.05

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing PLECANATIDE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
TRULANCE 3 MG TABLET
$18.0542
per EA
—

Frequently Asked Questions

What is Plecanatide used to treat?

Plecanatide is used to treat constipation, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Plecanatide?

In 2024, Medicare Part D spent $123 million on Plecanatide across 155,000 claims for 45,000 beneficiaries.

How many Plecanatide products are on the market?

The Plecanatide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Plecanatide?

NADAC reference prices for Plecanatide range from $18.0542 to $18.0542 per EA.

Which manufacturers make Plecanatide?

1 manufacturer lists Plecanatide in NADAC. Ranked by number of NDCs, the largest are Salix Pharmaceuticals Inc. (1).